Preliminary reports show conolidine could inhibit distinct ion channels, cutting down neuronal excitability and limiting ache signals. This mechanism is particularly applicable in neuropathic pain, exactly where abnormal signaling leads to persistent discomfort. In addition, conolidine appears to influence G protein-coupled receptor (GPCR) pathways